UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021120
Receipt number R000023995
Scientific Title Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery
Date of disclosure of the study information 2016/04/01
Last modified on 2019/05/21 08:56:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery

Acronym

Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery (OCEAN-SFA study)

Scientific Title

Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery

Scientific Title:Acronym

Open-label multicenter registry on the Outcomes of peripheral arterial disease treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery (OCEAN-SFA study)

Region

Japan


Condition

Condition

peripheral arterial disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will perform balloon angioplasty for treatment of de novo superficial femoral artery lesions, and we evaluate vascular responses at the site of balloon angioplasty by (OFDI). We identify the factors defining restenosis by evaluating the relationships between OFDI findings and presence of restenosis at 6 months after balloon angioplasty in this prospective registry.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

presence of restenosis by ultrasound at 6 months after balloon angioplasty

Key secondary outcomes

Rutherford category at 6 months after balloon angioplasty


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Optical Frequency Domain Imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)patients diagnosed as peripheral arterial disease and scheduled endvascular therapy for de novo superficial femoral artery lesions
2)patients aged over 20 years at the time of informed consent
3)patients who can undestand this study and provide informed consent written
4)ankle brachial index 0.9
5)PAD(Tasc A or B categories)
6)PAD(Rutherford 1-5 categories)

Key exclusion criteria

1)terminal illness in whom life expectancy is expected to be less than 6 months
2)previous stent implantation in the
targeted SFA lesion
3)acute limb ischemia or acute thrombotic occlusion
4)patients with no arterial runoff below the knee
5)patients with uncontrollable heart failure
6)patients can not recieve antiplatelet therapy
7)female patients during pregnancy or breast-feeding
8)patients who are judged inappropriate for this trial by their attending physician

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hirata Ken-ichi

Organization

Department of Internal Medicine, Kobe University Graduate School of Medicine

Division name

Division of Cardiovascular Medicine

Zip code


Address

7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo

TEL

078-382-5111

Email

hiratak@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiro Tsukiyama

Organization

Department of Internal Medicine, Kobe University Graduate School of Medicine

Division name

Division of Cardiovascular Medicine

Zip code


Address

7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo

TEL

078-382-5111

Homepage URL


Email

yoshiro.tsukiyama0920@gmail.com


Sponsor or person

Institute

Department of Internal Medicine, Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

DAIICHI SANKYO COMPANY

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 10 Day

Date of IRB

2016 Year 03 Month 23 Day

Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date

2018 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 21 Day

Last modified on

2019 Year 05 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023995


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name